Cargando…

Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes

Detalles Bibliográficos
Autores principales:	Dhurandhar, Nikhil V., Akheruzzaman, Md, Hegde, Vijay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422666/ https://www.ncbi.nlm.nih.gov/pubmed/32788586 http://dx.doi.org/10.1038/s41387-020-00133-0

Ejemplares similares

E4orf1 protein reduces the need for endogenous insulin
por: Peddibhotla, Swetha, et al.
Publicado: (2019)

E4orf1, an Adeno-viral protein, attenuates renal lipid accumulation in high fat fed mice: A novel approach to reduce a key risk factor for chronic kidney disease
por: Afruza, Rownock, et al.
Publicado: (2020)

Reducing endogenous insulin is linked with protection against hepatic steatosis in mice
por: Akheruzzaman, Md, et al.
Publicado: (2020)

Antidiabetic E4orf1 protein prevents hepatic steatosis and reduces markers of aging-related cellular damage in high fat fed older mice
por: Mostofinejad, Zahra, et al.
Publicado: (2021)

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19
por: Shah, Harsh, et al.
Publicado: (2021)

E4orf1 improves adipose tissue-specific metabolic risk factors and indicators of cognition function in a mouse model of Alzheimer’s disease
por: Khan, Md Shahjalal Hossain, et al.
Publicado: (2023)

E4orf1 Prevents Progression of Fatty Liver Disease in Mice on High Fat Diet
por: Afruza, Rownock, et al.
Publicado: (2022)

Potential therapeutic role of budesonide to reduce COVID-19 severity
por: Mohiuddin, Md, et al.
Publicado: (2022)

Doxycycline-Regulated 3T3-L1 Preadipocyte Cell Line with Inducible, Stable Expression of Adenoviral E4orf1 Gene: A Cell Model to Study Insulin-Independent Glucose Disposal
por: Krishnapuram, Rashmi, et al.
Publicado: (2013)

Current formula for calculating body mass index is applicable to Asian populations
por: Misra, Anoop, et al.
Publicado: (2019)

E4orf1: A Novel Ligand That Improves Glucose Disposal in Cell Culture
por: Dhurandhar, Emily J., et al.
Publicado: (2011)

A MetAP2 inhibitor blocks adipogenesis, yet improves glucose uptake in cells
por: Siddik, Md Abu Bakkar, et al.
Publicado: (2019)

E4orf1 Enhances Glucose Uptake Independent of Proximal Insulin Signaling
por: Na, Ha-Na, et al.
Publicado: (2016)

E4orf1: A protein for enhancing glucose uptake despite impaired proximal insulin signaling
por: Shastri, Anuradha A., et al.
Publicado: (2018)

Exploration of potential risk factors for COVID-19 severity in patients participating in oncology clinical trials
por: Mohiuddin, Md, et al.
Publicado: (2021)

E4orf1 Improves Lipid and Glucose Metabolism in Hepatocytes: A Template to Improve Steatosis & Hyperglycemia
por: Dhurandhar, Emily J., et al.
Publicado: (2012)

Cellular senescence is a potential severity factor for COVID-19: Suitable targets required to eliminate cellular senescence
por: Mohiuddin, Md, et al.
Publicado: (2021)

The Relation of the Non-modifiable (Destiny) and Modifiable (Free Will) Factors in Metabolic Derangements
por: Joshi, Ameya S., et al.
Publicado: (2018)

Interplay of pro- and anti-inflammatory cytokines to determine lipid accretion in adipocytes
por: Wang, Yanning, et al.
Publicado: (2013)

Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer’s Disease
por: Khan, Md Shahjalal Hossain, et al.
Publicado: (2020)

E4orf1 induction in adipose tissue promotes insulin-independent signaling in the adipocyte
por: Kusminski, Christine M., et al.
Publicado: (2015)

Severe Hypoglycemia and Cardiovascular Disease in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2015)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
por: Arabi, Yaseen M., et al.
Publicado: (2020)

Severity of COVID-19 and diabetes mellitus: there is still a lot to be learned
por: Rodacki, Melanie
Publicado: (2020)

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Strategies to Reduce the Cost of Renal Complications in Patients With Type 2 Diabetes
por: Gilmer, Todd P., et al.
Publicado: (2011)

Sleep and circadian phenotypes: risk factors for COVID-19 severity?
por: Gao, Lei, et al.
Publicado: (2022)

Prevention and management of type 2 diabetes: Potential role of genomics
por: Mahajan, Rajiv, et al.
Publicado: (2014)

Redox unbalance modifies neurogenic potential
por: Raciti, Marilena, et al.
Publicado: (2016)

COVID-19 screening in a healthcare or community setting: complexity of saliva as a specimen for PCR-based testing
por: Sahajpal, Nikhil Shri, et al.
Publicado: (2020)

Vitamin D’s Role in Reducing Risk of SARS-CoV-2 and COVID-19 Incidence, Severity, and Death
por: Grant, William B.
Publicado: (2021)

Potential Therapeutic Effects of Nitrate/Nitrite and Type 2 Diabetes Mellitus
por: Ghasemi, Asghar, et al.
Publicado: (2013)

Editorial: The National COVID Cohort Collaborative Consortium Combines Population Data with Machine Learning to Evaluate and Predict Risk Factors for the Severity of COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Post-COVID-19 syndrome and type 2 diabetes: Primacy of exercise in prevention and management
por: Jayasinghe, Sisitha, et al.
Publicado: (2022)

The emerging role of oxidative stress in complications of COVID-19 and potential therapeutic approach to diminish oxidative stress
por: Mohiuddin, Md, et al.
Publicado: (2021)

Potential of OneTouch Diabetes Management Software System in Real Field for Korean Type 2 Diabetes Patients
por: Kang, Borami, et al.
Publicado: (2016)

The Autonomous Nervous System: A Novel and Potentially Modifiable Risk Factor for Chronic Obstructive Pulmonary Disease in the Population?
por: Hamrefors, Viktor
Publicado: (2023)

Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection
por: Norouzi, Mahnaz, et al.
Publicado: (2021)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes
por: Rocha, Viviane Z., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b892gik9e4h7v065l1co2pqfaj